NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is a publicly traded Healthcare sector company. As of July 5, 2026, NAMS trades at $34.83 with a market cap of $4.07B and a P/E ratio of -19.46. NAMS moved -1.08% today. Year to date, NAMS is +0.26%; over the trailing twelve months it is +83.70%. Its 52-week range spans $14.06 to $42.21. Analyst consensus is strong buy with an average price target of $47.86. Rallies surfaces NAMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NAMS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $34.83 |
| Market Cap | $4.07B |
| P/E Ratio | -19.46 |
| EPS | $-1.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.21 |
| 52-Week Low | $14.06 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $22.57M |
| Net Income | $-212.73M |
| Gross Margin | 0.00% |
10 analysts cover NAMS: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $47.86.